Nuclear Medicine and Biology

Article	Citations
Review on 99mTc radiopharmaceuticals with emphasis on new advancements	77
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations	46
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion	43
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far	39
Production, purification and availability of 211At: Near term steps towards global access	37
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historica	37
A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3	34
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours	29
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology	29
The development of 11C-carbonylation chemistry: A systematic view	25
Alpha emitting nuclides for targeted therapy	25
Gold nanoparticles meet medical radionuclides	22
Neutron-activated theranostic radionuclides for nuclear medicine	20
Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides	19
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals	19
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18	18
18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging	17
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb	16
Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors	16
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent	16
High-throughput radio-TLC analysis	16
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue	15
A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian ca	15
Review: PET imaging with macro- and middle-sized molecular probes	14
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience	14

Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11	14
The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence	14
Auger: The future of precision medicine	14
Combination radionuclide therapy: A new paradigm	13
Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma	13
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models	12
[89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure	12
Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging	12
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies	12
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production	11
Radioarsenic: A promising theragnostic candidate for nuclear medicine	11
Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors	11
Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging	11
In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration	11
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy	10
Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1	10
One-step 18F-fluorination of smart positron emission tomography tracer for sensing furin activity in tumors	10
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer	10
Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease	10
A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models	10
Radiolabeling with [11C]HCN for Positron emission tomography	10
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain	10
2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation	9
Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb	9
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer	9
Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model	9
Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors	9
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals	9
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET	9
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody	9
[99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas	8
Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers	8
Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras	8
High-yield cyclotron production of 203Pb using a sealed 205Tl solid target	8
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging	8
Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins	8
New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles	8
68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics	7
Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease	7
Bismuth chelation for targeted alpha therapy: Current state of the art	7
Training the next generation of radiopharmaceutical scientists	7
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic	7
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain	7
Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac	7
Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe	7
AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions	7
45Ti targeted tracers for PET imaging of PSMA	6
[11C]phosgene: Synthesis and application for development of PET radiotracers	6
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals	6
A decade of ubiquicidin development for PET imaging of infection: A systematic review	6

A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation	6
Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma	6
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications	6
Passive and receptor mediated brain delivery of an anti-GFAP nanobody	6
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons	6
Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides	6
Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs	6
Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands	6
[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma	6
[68Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent	6
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu	6
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines	6
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells	6
Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy	5
Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guani	5
Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex	5
Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma	5
RETRACTED: Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors	5
[68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair	5
Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d2: A comparison with [18F]FDG	5
18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach	5
Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue	5
PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data	5
68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma	5
EXIRAD-3D: Fast automated three-dimensional autoradiography	5
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine	5
HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging	5
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy	5
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model	5
Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer	5
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging	5
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold	5
Immuno-imaging of ICAM-1 in tumours by SPECT	5
Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain	5
Development of a PET radioligand selective for cerebral amyloid angiopathy	4
GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study	4
Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713	4
Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)	4
News ways of understanding the complex biology of diabetes using PET	4
Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents	4
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation	4
Synthesis and evaluation of zirconium-89 labelled and long-lived GLP-1 receptor agonists for PET imaging	4
Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer	4
A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator	4
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications	4
In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain	4
Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution	4
Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX	4
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation	4
Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy	4
An original radio-biomimetic approach to synthesize radiometabolites for PET imaging	4
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations	4
Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans	4
Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model	3
Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta)	3
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes	3
Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results	3
Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas	3
A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept	3
Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO	3
First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor	3
Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics	3
Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy	3
Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators	3
Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib	3
Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells	3
Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling	3
Applying radiobiology to clinical molecular radiotherapy	3
Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies	3
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase	3
Evaluation and selection of a lead diabody for interferon-γ PET imaging	3
Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT	3
Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging	3
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)	3
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer	3
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM	3
Characterization of actinide resin for separation of 51,52gMn from bulk target material	3
Tracer development for PET imaging of proteinopathies	3
Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage	2
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy	2

A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy	2
Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2	2
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation	2
Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2	2
Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging	2
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target	2
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy	2
p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide	2
Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2	2
Automated production of [11C]butyrate for keto body PET imaging	2
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4	2
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer	2
Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers	2
Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides	2
A new in silico approach to revolutionize CNS PET tracer design and enhance translational success	2
Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer	2
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain	2
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging	2
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues	2
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry	2
Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers	2
First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer	2
Laminated holmium-166-containing electrospun bandages for use against skin cancer	2
Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography	2
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents?	2
Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds	2
The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC	2
Radiopharmacy in Africa: current status and future directions	2
Rapid detection of SARS-CoV-2 using a radiolabeled antibody	2
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy	2
Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy	2
GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726	2
Copper-61 from liquid targets: optimized purification for GMP labelling	1
Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals	1
Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis	1
223Ra-radiolabeling: predicting stability using molecular modelling	1
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5	1
Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO	1
Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43	1
Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits	1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG	1
Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches	1
Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles	1
Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform	1
Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET	1
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers	1
Integrin αvβ3 and EGFR dual-targeted [64Cu]Cu-NOTA-RGD-GE11 heterodimer for PET imaging in pancreatic cancer mouse model	1
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study	1
Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging	1
[99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers	1
The effect of base strengths on the radiochemical yields of S[18F]FB synthesis	1
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP	1
Imaging of microglia in post-stroke inflammation	1
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC	1
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply	1
Development and exploration of bifunctional chelating ligands for mercury-197m/g	1
Production of 117mSn using Sb alloy targetry	1
Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid	1
Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid	1
The synthesis and bioevaluation of a novel and brain penetrable PARP1 tracer [18F]Pamiparib in rodents and nonhuman primates	1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours	1
Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer	1
18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media	1
Radiolabeling and biological evaluation of functionalized spherical nucleic acids	1
[18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model	1
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor	1
Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia	1
Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic	1
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo	1
Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate	1
Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome	1
A brief history of the Society of Radiopharmaceutical Sciences	1
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity	1
Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation	1
Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)	1
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3	1
One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module	1
Rhenium and technetium complexes in extremely low oxidation states	1
Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111	1
Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands	1
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice	1
Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor	1
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity	1
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist	1
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2	1
18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2	1
Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen	1
Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies	1
Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78	1
Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11	1
Status of radiobiology in molecular radionuclide therapy – Hope for the future	1
Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1	1
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers	0
[18F]Talazoparib: a novel potential PET imaging agent of PARP	0
Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands	0